CONFERENCES

      International Multiconference “Bioinformatics of Genome Regulation and Structure/Systems Biology

      International Multiconference “Bioinformatics of Genome Regulation and Structure/Systems Biology, or BGRS/SB, hosted by Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences (ICG SB RAS), is an biennial conference that focuses on bioinformatics and systems biology research, with topics ranging from genomics to network analysis. The conference is aimed at researchers, computer scientists, and other professionals involved in the development and use of computational methods in biology, and provides a forum for sharing knowledge and collaborating on new approaches to understanding complex biological systems.

      BGRS/SB 2020

      Date

      Jul 04, 2020 - Jul 08, 2020

      Location

      Online

      For the first time BGRS/SB-2020 is held without gathering in-person due to COVID-19 prevention measures. The main even is followed by satellite symposiums “Systems biology, bioinformatics and biomedicine” (SbioMed-2020) and “Mathematical Problems of Covid-19”.

      See related presentations

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.